Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: Correlation with clinical parameters and disease-free survival

Clinical Cancer Research

Volumn 3, Issue 1, 1997, Pages 103-109

  Rocha, Rafael L ^a   Hilsenbeck, Susan G ^a   Jackson, James G ^a   VanDenBerg, Carla L ^a   Weng, Chye Ning ^a   Lee, Adrian V ^a   Yee, Douglas ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PROGESTERONE RECEPTOR; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TUMOR VOLUME;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MIDDLE AGED; PHOSPHOPROTEINS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0031051830     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Yee, D. The insulin-like growth factor system as a target in breast cancer. Breast Cancer Res. Treat., 32: 85-95, 1994.
2. Ellis, M. J. C, Leav, B. A., Yang, Z., Rasmussen, A., Pearce, A., Zweibel, J. A., Lippman, M. A., and Cullen, K. J. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells. Mol. Endocrinol., 10: 286-297, 1996.
3. Jones, J. I., and Clemmons, D. R. Insulin-like growth factors and their binding proteins: biological actions. Endocr, Rev., 16: 3-34, 1996.
4. DeMellow, J. S. M., and Baxter, R. C. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and po- tentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun., 156: 199-204, 1988.
5. Oh, Y. M., Muller, H. L., Lamson, G., and Rosenfeld, R. G. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells-cell surface binding and growth inhibition. J. Biol. Chem., 268: 14964-14971, 1993.
6. Oh, Y., Muller, L., Ng, L., and Rosenfeld, R. G. Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J. Biol. Chem., 270: 13589-13592, 1995.
7. Gucev, Z. S., Oh, Y., Kelley, K. M., and Rosenfeld, R. G. Insulinlike growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta 2-induced growth inhibition in human breast cancer cells. Cancer Res., 56: 1545-1550, 1996.
8. Chen, J. C, Shao, Z, M., Sheikh, M. S., Hussain, A., Leroith, D., Roberts, C. T., and Fontana, J. A. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J. Cell. Physiol., 755: 69-78, 1994.
9. Myers, M. G., Grammer, T, C., Wang, L. M., Sun, X. J., Pierce, J. H., Blenis, J., and White, M. F. Insulin receptor substrate-1 mediates phosphatidylinositol 3′-kinase and p70(S6k) signaling during insulin, insulinlike growth factor-1, and interieukin-4 stimulation. J. Biol. Chem., 269: 28783-28789, 1994.
10. Surmacz, E., and Burgaud, J-L. Overexpression of insulin receptor substrate 1 (IRS-1) in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation. Clin. Cancer Res., 1: 1429-1436, 1995.
11. Costantino, A., Milazzo, G., Giorgino, F., Russo, P., Goldfine, I. D., Vigneri, R., and Belfiore, A. Insulin-resistant MDA-MB-231 human breast cancer cells contain a tyrosine kinase inhibiting activity. Mol. Endocrinol., 7: 1667-1676, 1993.
12. Sepp-Lorenzino, L., Rosen, N., and Lebwohl, D. E. Insulin and insulin-like growth factor signaling are defective in the MDA MB-468 human breast cancer cell line. Cell Growth Differ., 5: 1077-1083, 1994.
13. Papa, V., Gliozzo, B., Clark, G. M., McGuire, W. L., Moore, D., Fujita-yamaguchi, Y., Vigneri, R., Goldfine, I. D., and Pezzino, V. Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res., 53: 3736-3740, 1993.
14. Rocha, R. L., Hilsenbeck, S. G., Jackson, J. G., Lee, A. V., Figueroa, J. A., and Yee, D. Insulin-like growth factor binding protein-3 mRNA and protein expression are correlated in primary breast cancer tissues: higher levels are detected in tumors with poor prognostic features. J. Natl. Cancer Inst., 88: 601-606, 1996.
15. Yee, D., Sharma, J., and Hilsenbeck, S. G. Prognostic significance of insulin-like growth factor-binding protein expression in axillary lymph node-negative breast cancer. J. Natl. Cancer Inst., 86: 1785-1789, 1994.
16. Kaplan, E. L., and Meier, P. L. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
17. Cox, D. R., and Oakes, D. Analysis of Survival Data. New York: Chapman and Hall, 1984.
18. Cox, D. R. Regression models and life-tables. J. R. Statist. Soc. B., 34: 187-200, 1972.
19. Wenger, C. R., Beardslee, S., Owens, M. A., Pounds, G., Oldaker, T., Vendely, P., Pandian, M. R., Harrington, D., Clark, G. M., and McGuire, W. L. DNA ploidy, S-phase, and steroid receptors in more than 127,000 breast cancer patients. Breast Cancer Res, Treat., 28: 9-20, 1993.
20. Aronica, S. M., and Katzenellenbogen, B. S. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I. Mol. Endocrinel., 7: 743-752, 1993.
21. McGuire, W. L., Jr., Jackson, J. G., Figueroa, J. A., Shimasaki, S., Powell, D. R., and Yee, D. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J. Natl. Cancer Inst., 84: 1336-1341, 1992.
22. Figueroa, J. A., Yee, D., and McGuire, W. L. Prognostic indicators in early breast cancer. Am. J. Med. Sci., 305: 176-182, 1993.
23. Pekonen, F., Nyman, T., Ilvesmaki, V., and Partanen, S. Insulin-like growth factor binding proteins in human breast cancer tissue. Cancer Res., 52: 5204-5207, 1992.
24. Figueroa, J. A., Jackson, J. G., McGuire, W. L., Krywicki, R. F., and Yee, D. Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status. J. Cell. Biochem., 52; 196-205, 1993.
25. Clemmons, D. R., Camacho-Hubner, C., Coronado, E., and Osborne, C. K. Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology, 127: 2679-2686, 1990.
26. McGuire, S. E., Hilsenbeck, S. G., Figueroa, J. A., Jackson, J. G., and Yee, D. Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues. Cancer Lett., 77: 25-32, 1994.
27. Yee, D., Favoni, R. E., Lippman, M. E., and Powell, D. R. Identification of insulin-like growth factor binding proteins in breast cancer cells. Breast Cancer Res. Treat., 18: 3-10, 1991.
28. Saceda, M., Lippman, M. E., Lindsey, R. K., Montserrat, P., and Martin, M. B. Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells. Mol. Endocrinol., 3: 1782-1787, 1989.
29. Wosikowski, K., Kung, W., Hasmann, M., Loser, R., and Eppenberger, U. Inhibition of growth-factor-activated proliferation by antiestrogens and effects on early gene expression in MCF-7 cells. Int. J. Cancer, 53: 290-297, 1993.
30. Yee, D., Jackson, J. G., Kozelsky, T. W., and Figueroa, J. A. Insulin-like growth factor binding protein-1 (IGFBP-1) expression inhibits IGF-I action in MCF-7 breast cancer cells. Cell Growth Differ., 5: 73-77, 1994.
31. Figueroa, J. A., Sharma, J., Jackson, J. G., McDermott, M. J., Hilsenbeck, S. G., and Yee, D. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells. J. Cell. Physiol., 157: 229-236, 1993.